Literature DB >> 16857014

Characterization of natural vasostatin-containing peptides in rat heart.

Elise Glattard1, Tommaso Angelone, Jean-Marc Strub, Angelo Corti, Dominique Aunis, Bruno Tota, Marie-Hélène Metz-Boutigue, Yannick Goumon.   

Abstract

Chromogranin A (CGA) is a protein that is stored and released together with neurotransmitters and hormones in the nervous, endocrine and diffuse neuroendocrine systems. As human vasostatins I and II [CGA(1-76) and CGA(1-113), respectively] have been reported to affect vessel motility and exert concentration-dependent cardiosuppressive effects on isolated whole heart preparations of eel, frog and rat (i.e. negative inotropism and antiadrenergic activity), we investigated the presence of vasostatin-containing peptides in rat heart. Rat heart extracts were purified by RP-HPLC, and the resulting fractions analyzed for the presence of CGA N-terminal fragments using dot-blot analysis. CGA-immunoreactive fractions were submitted to western blot and MS analysis using the TOF/TOF technique. Four endogenous N-terminal CGA-derived peptides [CGA(4-113), CGA(1-124), CGA(1-135) and CGA(1-199)] containing the vasostatin sequence were characterized. The following post-translational modifications of these fragments were identified: phosphorylation at Ser96, O-glycosylation (trisaccharide, NAcGal-Gal-NeuAc) at Thr126, and oxidation at three methionine residues. This first identification of CGA-derived peptides containing the vasostatin motif in rat heart supports their role in cardiac physiology by an autocrine/paracrine mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16857014     DOI: 10.1111/j.1742-4658.2006.05334.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  11 in total

Review 1.  Cardiomyokines from the heart.

Authors:  Ayano Chiba; Haruko Watanabe-Takano; Takahiro Miyazaki; Naoki Mochizuki
Journal:  Cell Mol Life Sci       Date:  2017-12-13       Impact factor: 9.261

2.  Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart.

Authors:  Bhawanjit K Brar; Erik Helgeland; Sushil K Mahata; Kuixing Zhang; Daniel T O'Connor; Karen B Helle; Anne K Jonassen
Journal:  Regul Pept       Date:  2010-07-22

3.  The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes.

Authors:  Bruno Tota; Stefano Gentile; Teresa Pasqua; Eleonora Bassino; Hisatsugu Koshimizu; Niamh X Cawley; Maria C Cerra; Y Peng Loh; Tommaso Angelone
Journal:  FASEB J       Date:  2012-03-29       Impact factor: 5.191

Review 4.  Chromogranin A: a paradoxical player in angiogenesis and vascular biology.

Authors:  Karen B Helle; Angelo Corti
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

Review 5.  Chromogranin A: a novel susceptibility gene for essential hypertension.

Authors:  Bhavani S Sahu; Parshuram J Sonawane; Nitish R Mahapatra
Journal:  Cell Mol Life Sci       Date:  2009-11-27       Impact factor: 9.261

6.  The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.

Authors:  Tommaso Angelone; Anna Maria Quintieri; Bhawanjit K Brar; Pauline T Limchaiyawat; Bruno Tota; Sushil K Mahata; Maria Carmela Cerra
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

7.  Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart.

Authors:  Rosa Mazza; Alfonsina Gattuso; Cinzia Mannarino; Bhawanjit K Brar; Sandra Francesca Barbieri; Bruno Tota; Sushil K Mahata
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-09       Impact factor: 4.733

8.  Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384)).

Authors:  Nilima Biswas; Erica Curello; Daniel T O'Connor; Sushil K Mahata
Journal:  Cell Tissue Res       Date:  2010-11-05       Impact factor: 5.249

9.  Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure.

Authors:  Jens P Goetze; Linda M Hilsted; Jens F Rehfeld; Urban Alehagen
Journal:  Endocr Connect       Date:  2014-03-11       Impact factor: 3.335

Review 10.  The surging role of Chromogranin A in cardiovascular homeostasis.

Authors:  Bruno Tota; Tommaso Angelone; Maria C Cerra
Journal:  Front Chem       Date:  2014-08-14       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.